Who is sponsoring NCT04120142?

NCT04120142 is sponsored by Faculty of Medicine, Sousse.

What drugs are being tested in NCT04120142?

Interventions in NCT04120142: Pulmonary rehabilitation+IMT, Pulmonary rehabilitation.

What condition does NCT04120142 study?

NCT04120142 studies Chronic Obstructive Pulmonary Disease.

Is NCT04120142 still recruiting?

NCT04120142 is currently completed. Last updated 5 February 2020.

Last reviewed 2020-02-05 · How we verify

NCT04120142

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Inspiratory Muscle Training During PR on Dyspnoea and Exercise Tolerance in COPD Patients

Completed NA Last updated 5 February 2020

What this trial tests

NA trial testing Pulmonary rehabilitation+IMT in Chronic Obstructive Pulmonary Disease in 34 participants. Completed in 1 December 2019.

Timeline

1 February 2019

Primary endpoint
1 December 2019

1 December 2019

Quick facts

Lead sponsor	Faculty of Medicine, Sousse
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	34
Start date	1 February 2019
Primary completion	1 December 2019
Estimated completion	1 December 2019
Sites	1 location across Tunisia

Drugs / interventions tested

Pulmonary rehabilitation+IMT
Pulmonary rehabilitation

Conditions studied

Chronic Obstructive Pulmonary Disease — all drugs for Chronic Obstructive Pulmonary Disease →

Sponsor

Faculty of Medicine, Sousse

Who can join

Adults 45 to 75, male only, with Chronic Obstructive Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chronic obstructive pulmonary disease is a respiratory disease that results in progressive airflow limitation and respiratory distress. The benefit of inspiratory muscle training (IMT) combined with a pulmonary rehabilitation programme is uncertain. The investigators aimed to demonstrate that, in patients with obstructive pulmonary disease, IMT performed during a PRP is associated with an improvement of dyspnoea and exercise tolerance.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary disease (COPD).
Ammous O, Feki W, Lotfi T, Khamis AM, et al · · 2023 · cited 72× · PMID 36606682 · DOI 10.1002/14651858.cd013778.pub2

Verify or expand the search:

Other recruiting trials for Chronic Obstructive Pulmonary Disease

Currently open trials in the same condition.

NCT06749262 — Inclined Versus Standard Exercise for COPD Patients · NA · recruiting
NCT07406659 — Different Inspiratory Muscle Trainings in Patients With COPD · NA · recruiting
NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting
NCT07418736 — A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease · Phase 2 · recruiting
NCT07069829 — Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo · recruiting

Other Faculty of Medicine, Sousse trials

Trials by the same sponsor.

NCT07096037 — Safety and Efficacy of Urtica Dioica Cataplasm in the Management of Osgood-Schlatter Disease in Young Athletes · NA · not yet recruiting
NCT06926114 — Is Microlearning the Alternative in the Age of Hyperconnectivity · NA · enrolling by invitation
NCT06021834 — Effect of Physical Rehabilitation in Patients With Parkinson's Disease · NA · unknown
NCT06948669 — Brain Death and Organ Donation in Tunisian Intensive Care Units · completed
NCT07271550 — NAFF Arabic Validation Study · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04120142 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Faculty of Medicine, Sousse
Last refreshed: 5 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04120142.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing